Status:
COMPLETED
Survey on the Treatment of Hypertension in Patients With Type 2 Diabetes
Lead Sponsor:
AstraZeneca
Conditions:
Hypertension
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
Multi-centre survey of type 2 diabetic patients who are currently on anti-hypertensive treatment. Data collection for each patient will take place at one visit. To observe the proportion of diabetic p...
Eligibility Criteria
Inclusion
- Provision of written informed consent
- Patient was diagnosed with type 2 diabetes
- Patient is on antihypertensive treatments for at least 3 months, with the same regimen for a minimum of 4 weeks prior to survey
Exclusion
- Patients are critically ill, had mental health problems or difficulty in communication
- Patients who are unwilling or unable to provide informed consent
- Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site).
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2009
Estimated Enrollment :
1060 Patients enrolled
Trial Details
Trial ID
NCT00803660
Start Date
November 1 2008
End Date
May 1 2009
Last Update
July 9 2009
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Châu Đốc, An Giang, Vietnam
2
Research Site
Bạc Liêu, Bac Lieu, Vietnam
3
Research Site
Qui Nhon, Binh Dinh, Vietnam
4
Research Site
Cà Mau, Ca Mau, Vietnam